GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 60.98 USD 2.28% Market Closed
Market Cap: $1.8B

Balance Sheet

Balance Sheet Decomposition
GeneDx Holdings Corp

Balance Sheet
GeneDx Holdings Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
115
108
401
124
100
85
105
Cash Equivalents
115
108
401
124
100
85
105
Short-Term Investments
0
0
0
0
30
56
66
Total Receivables
22
32
27
43
33
38
74
Accounts Receivables
21
32
27
43
32
37
74
Other Receivables
0
0
0
1
0
0
0
Inventory
16
25
34
14
9
11
14
Other Current Assets
11
9
23
32
11
9
9
Total Current Assets
164
174
484
213
182
198
268
PP&E Net
35
63
63
84
59
59
69
PP&E Gross
35
63
63
84
59
59
69
Accumulated Depreciation
18
30
52
102
46
52
26
Intangible Assets
0
0
0
187
173
159
168
Goodwill
0
0
0
0
0
0
14
Other Long-Term Assets
5
14
8
7
4
4
4
Other Assets
0
0
0
0
0
0
14
Total Assets
204
N/A
252
+23%
554
+120%
491
-11%
419
-15%
419
+0%
524
+25%
Liabilities
Accounts Payable
18
27
45
48
10
8
8
Accrued Liabilities
15
34
45
82
44
42
84
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
5
3
4
2
2
5
Other Current Liabilities
5
8
9
11
3
3
12
Total Current Liabilities
40
73
101
144
59
55
109
Long-Term Debt
22
40
29
22
71
70
65
Deferred Income Tax
0
0
0
3
2
1
1
Other Liabilities
13
134
35
69
59
48
40
Total Liabilities
75
N/A
247
+228%
166
-33%
237
+43%
191
-20%
174
-9%
216
+24%
Equity
Common Stock
217
334
0
0
0
0
0
Retained Earnings
89
330
575
1 124
1 300
1 352
1 373
Additional Paid In Capital
0
0
964
1 378
1 528
1 597
1 681
Other Equity
0
0
0
0
0
1
1
Total Equity
128
N/A
4
-97%
388
+8 720%
254
-35%
228
-10%
245
+8%
308
+26%
Total Liabilities & Equity
204
N/A
252
+23%
554
+120%
491
-11%
419
-15%
419
+0%
524
+25%
Shares Outstanding
Common Shares Outstanding
7
7
7
12
26
28
29
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett